Frontera Therapeutics
Frontera Therapeutics
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gene Therapy for DME | diabetic macular edema | Recruiting | Phase 1 / Phase 2 | 2024-07-09 | NCT06492876 | |
| Gene Therapy(FT-003) for Wet AMD | Neovascular Age-related Macular Degeneration | Recruiting | Phase 1 / Phase 2 | 2024-07-09 | NCT06492863 | |
| Gene Therapy for Diabetic Macular Edema | diabetic macular edema | Recruiting | Phase 1 | 2023-06-23 | NCT05916391 | |
| Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa | X-Linked Retinitis Pigmentosa | Recruiting | Early phase 1 | 2023-05-24 | NCT05874310 | |
| Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy | Biallelic RPE65 Mutation-associated Retinal Dystrophy | Recruiting | Phase 1 / Phase 2 | 2023-05-15 | NCT05858983 | |
| Gene Therapy for Wet AMD | Neovascular Age-related Macular Degeneration | Not yet recruiting | Phase 1 | 2023-04-26 | NCT05611424 |